-- Elbit Medical Gains to Two Week-High on Unitâ€™s Marketing Update
-- B y   S h o s h a n n a   S o l o m o n
-- 2012-07-04T10:41:52Z
-- http://www.bloomberg.com/news/2012-07-04/elbit-medical-gains-to-two-week-high-on-unit-s-marketing-update.html
Elbit Medical Technologies Ltd. (EMTC) 
advanced to the highest in two weeks after the company with
stakes in medical-device manufacturers said a unit expects to
get permission in 2014 to market a product in the U.S.  Shares of the Tel Aviv-based company surged 4.7 percent to
0.133 shekel at 11:59 a.m. in  Tel Aviv .  Elbit Medical said Gamida Cell expects to get approval
during 2014 to market its StemEx drug, for the treatment of
leukemia and lymphoma, in the U.S. Elbit has a 30.8 percent
stake in Gamida.  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  